vs

Side-by-side financial comparison of PROCEPT BioRobotics Corp (PRCT) and TELOS CORP (TLS). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $46.8M, roughly 1.8× TELOS CORP). TELOS CORP runs the higher net margin — -34.9% vs -38.1%, a 3.2% gap on every dollar of revenue. On growth, TELOS CORP posted the faster year-over-year revenue change (77.4% vs 20.2%). Over the past eight quarters, TELOS CORP's revenue compounded faster (25.7% CAGR vs 24.8%).

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

Telos Corporation is an information technology and cybersecurity company located in Ashburn, Virginia. Telos primarily serves government and enterprise clients, receiving a large number of its contracts from the United States Department of Defense. Customers are primarily military, intelligence and civilian agencies of the US government and NATO allies.

PRCT vs TLS — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.8× larger
PRCT
$83.1M
$46.8M
TLS
Growing faster (revenue YoY)
TLS
TLS
+57.2% gap
TLS
77.4%
20.2%
PRCT
Higher net margin
TLS
TLS
3.2% more per $
TLS
-34.9%
-38.1%
PRCT
Faster 2-yr revenue CAGR
TLS
TLS
Annualised
TLS
25.7%
24.8%
PRCT

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
PRCT
PRCT
TLS
TLS
Revenue
$83.1M
$46.8M
Net Profit
$-31.6M
$-16.3M
Gross Margin
64.9%
35.0%
Operating Margin
-4.1%
-39.6%
Net Margin
-38.1%
-34.9%
Revenue YoY
20.2%
77.4%
Net Profit YoY
-27.9%
-74.8%
EPS (diluted)
$-0.56
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PRCT
PRCT
TLS
TLS
Q1 26
$83.1M
Q4 25
$76.4M
$46.8M
Q3 25
$83.3M
$51.4M
Q2 25
$79.2M
$36.0M
Q1 25
$69.2M
$30.6M
Q4 24
$68.2M
$26.4M
Q3 24
$58.4M
$23.8M
Q2 24
$53.4M
$28.5M
Net Profit
PRCT
PRCT
TLS
TLS
Q1 26
$-31.6M
Q4 25
$-29.8M
$-16.3M
Q3 25
$-21.4M
$-2.1M
Q2 25
$-19.6M
$-9.5M
Q1 25
$-24.7M
$-8.6M
Q4 24
$-18.9M
$-9.3M
Q3 24
$-21.0M
$-28.1M
Q2 24
$-25.6M
$-7.8M
Gross Margin
PRCT
PRCT
TLS
TLS
Q1 26
64.9%
Q4 25
60.6%
35.0%
Q3 25
64.8%
39.9%
Q2 25
65.4%
33.2%
Q1 25
63.9%
39.8%
Q4 24
64.0%
40.3%
Q3 24
63.2%
13.2%
Q2 24
59.0%
34.1%
Operating Margin
PRCT
PRCT
TLS
TLS
Q1 26
-4.1%
Q4 25
-40.6%
-39.6%
Q3 25
-27.8%
-4.8%
Q2 25
-28.0%
-27.5%
Q1 25
-39.7%
-29.5%
Q4 24
-28.9%
-37.6%
Q3 24
-38.4%
-121.4%
Q2 24
-50.3%
-30.3%
Net Margin
PRCT
PRCT
TLS
TLS
Q1 26
-38.1%
Q4 25
-39.1%
-34.9%
Q3 25
-25.7%
-4.1%
Q2 25
-24.7%
-26.5%
Q1 25
-35.8%
-28.1%
Q4 24
-27.6%
-35.4%
Q3 24
-35.9%
-118.0%
Q2 24
-48.0%
-27.2%
EPS (diluted)
PRCT
PRCT
TLS
TLS
Q1 26
$-0.56
Q4 25
$-0.54
$-0.22
Q3 25
$-0.38
$-0.03
Q2 25
$-0.35
$-0.13
Q1 25
$-0.45
$-0.12
Q4 24
$-0.34
$-0.13
Q3 24
$-0.40
$-0.39
Q2 24
$-0.50
$-0.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PRCT
PRCT
TLS
TLS
Cash + ST InvestmentsLiquidity on hand
$245.6M
$53.2M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$347.7M
$96.0M
Total Assets
$487.1M
$139.9M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PRCT
PRCT
TLS
TLS
Q1 26
$245.6M
Q4 25
$286.5M
$53.2M
Q3 25
$294.3M
$59.0M
Q2 25
$302.7M
$57.0M
Q1 25
$316.2M
$57.8M
Q4 24
$333.7M
$54.6M
Q3 24
$196.8M
$69.8M
Q2 24
$214.1M
$80.1M
Total Debt
PRCT
PRCT
TLS
TLS
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
PRCT
PRCT
TLS
TLS
Q1 26
$347.7M
Q4 25
$365.9M
$96.0M
Q3 25
$380.3M
$119.7M
Q2 25
$385.8M
$118.4M
Q1 25
$389.2M
$126.1M
Q4 24
$402.2M
$127.1M
Q3 24
$241.2M
$129.5M
Q2 24
$251.8M
$149.1M
Total Assets
PRCT
PRCT
TLS
TLS
Q1 26
$487.1M
Q4 25
$508.1M
$139.9M
Q3 25
$511.5M
$164.3M
Q2 25
$513.1M
$165.0M
Q1 25
$519.4M
$158.1M
Q4 24
$534.0M
$158.2M
Q3 24
$374.1M
$166.3M
Q2 24
$374.4M
$182.4M
Debt / Equity
PRCT
PRCT
TLS
TLS
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PRCT
PRCT
TLS
TLS
Operating Cash FlowLast quarter
$8.0M
Free Cash FlowOCF − Capex
$8.0M
FCF MarginFCF / Revenue
17.0%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$29.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PRCT
PRCT
TLS
TLS
Q1 26
Q4 25
$-10.3M
$8.0M
Q3 25
$-6.6M
$9.1M
Q2 25
$-15.0M
$7.0M
Q1 25
$-17.0M
$6.1M
Q4 24
$-32.4M
$-10.5M
Q3 24
$-18.8M
$-7.1M
Q2 24
$-15.7M
$-8.0M
Free Cash Flow
PRCT
PRCT
TLS
TLS
Q1 26
Q4 25
$-12.2M
$8.0M
Q3 25
$-9.5M
$8.7M
Q2 25
$-17.8M
$6.8M
Q1 25
$-18.8M
$6.0M
Q4 24
$-33.6M
$-12.4M
Q3 24
$-19.0M
$-7.1M
Q2 24
$-16.8M
$-8.2M
FCF Margin
PRCT
PRCT
TLS
TLS
Q1 26
Q4 25
-15.9%
17.0%
Q3 25
-11.4%
16.9%
Q2 25
-22.5%
19.0%
Q1 25
-27.2%
19.5%
Q4 24
-49.2%
-47.0%
Q3 24
-32.6%
-30.0%
Q2 24
-31.4%
-28.9%
Capex Intensity
PRCT
PRCT
TLS
TLS
Q1 26
Q4 25
2.4%
0.1%
Q3 25
3.4%
0.9%
Q2 25
3.5%
0.4%
Q1 25
2.7%
0.4%
Q4 24
1.7%
7.1%
Q3 24
0.4%
0.2%
Q2 24
2.0%
0.8%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

TLS
TLS

Security Solutions Segment$44.8M96%
Secure Networks Segment$1.9M4%

Related Comparisons